BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29074395)

  • 1. Epigenetics of malignant melanoma.
    Moran B; Silva R; Perry AS; Gallagher WM
    Semin Cancer Biol; 2018 Aug; 51():80-88. PubMed ID: 29074395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2: an emerging role in melanoma biology and strategies for targeted therapy.
    Tiffen J; Gallagher SJ; Hersey P
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):21-30. PubMed ID: 24912396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
    Christofides A; Karantanos T; Bardhan K; Boussiotis VA
    Oncotarget; 2016 Dec; 7(51):85624-85640. PubMed ID: 27793053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
    Barsotti AM; Ryskin M; Zhong W; Zhang WG; Giannakou A; Loreth C; Diesl V; Follettie M; Golas J; Lee M; Nichols T; Fan C; Li G; Dann S; Fantin VR; Arndt K; Verhelle D; Rollins RA
    Oncotarget; 2015 Feb; 6(5):2928-38. PubMed ID: 25671303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on melanoma epigenetics.
    de Unamuno B; Palanca S; Botella R
    Curr Opin Oncol; 2015 Sep; 27(5):420-6. PubMed ID: 26197354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics of human melanoma: promises and challenges.
    Besaratinia A; Tommasi S
    J Mol Cell Biol; 2014 Oct; 6(5):356-67. PubMed ID: 24895357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma epigenetics: novel mechanisms, markers, and medicines.
    Lee JJ; Murphy GF; Lian CG
    Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics of melanoma: implications for immune-based therapies.
    Fratta E; Sigalotti L; Covre A; Parisi G; Coral S; Maio M
    Immunotherapy; 2013 Oct; 5(10):1103-16. PubMed ID: 24088079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 5-hydroxymethylcytosine in melanoma.
    Li FJ; Li LM; Zhang RH; Xu C; Zhou P; Long J; Hu G; Jiang MJ
    Melanoma Res; 2017 Jun; 27(3):175-179. PubMed ID: 28225433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics and epigenetics of cutaneous malignant melanoma: a concert out of tune.
    van den Hurk K; Niessen HE; Veeck J; van den Oord JJ; van Steensel MA; Zur Hausen A; van Engeland M; Winnepenninckx VJ
    Biochim Biophys Acta; 2012 Aug; 1826(1):89-102. PubMed ID: 22503822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A primer for epigenetics of hematological malignancies].
    Nakajima H
    Rinsho Ketsueki; 2016; 57(10):1835-1844. PubMed ID: 27725578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
    Guo X; Xu Y; Zhao Z
    Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma.
    Fang M; Hutchinson L; Deng A; Green MR
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1250-5. PubMed ID: 26787892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruiting polycomb to chromatin.
    van Kruijsbergen I; Hontelez S; Veenstra GJ
    Int J Biochem Cell Biol; 2015 Oct; 67():177-87. PubMed ID: 25982201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic events in malignant melanoma.
    Rothhammer T; Bosserhoff AK
    Pigment Cell Res; 2007 Apr; 20(2):92-111. PubMed ID: 17371436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics in human melanoma.
    Howell PM; Liu S; Ren S; Behlen C; Fodstad O; Riker AI
    Cancer Control; 2009 Jul; 16(3):200-18. PubMed ID: 19556960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.
    Anestopoulos I; Kyriakou S; Tragkola V; Paraskevaidis I; Tzika E; Mitsiogianni M; Deligiorgi MV; Petrakis G; Trafalis DT; Botaitis S; Giatromanolaki A; Koukourakis MI; Franco R; Pappa A; Panayiotidis MI
    Pharmacol Ther; 2022 Dec; 240():108301. PubMed ID: 36283453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation and histone acetylation regulate the expression of MGMT and chemosensitivity to temozolomide in malignant melanoma cell lines.
    Chen YP; Hou XY; Yang CS; Jiang XX; Yang M; Xu XF; Feng SX; Liu YQ; Jiang G
    Tumour Biol; 2016 Aug; 37(8):11209-18. PubMed ID: 26943799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.